comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-01 15:29:46 - browse：95

Hevolution's executive team includes, from left, Sophia Pathai, Haya Bint Khaled Bin Bandar Al Saud, Mehmood Khan, and Salman AlAsiry. Courtesy Hashem Al-Sh

The Hevolution Foundation, a Saudi investment firm focused on aging science, said Wednesday that it is launching an incubator that will bring together experts from the scientific community, pharma, and multiple biotech VCs.

The incubator, called the Breakthrough Innovation Alliance, will give up to $1 million apiece to 10 different research initiatives over the next three years, allowing scientists and entrepreneurs to run preclinical research to determine whether the ideas hold any promise. The projects will be evaluated by a committee made up of representatives from Hevolution, Novo Nordisk, 5AM Ventures, RA Capital, and drug company EvoTec. The best projects will become the basis of new startups, co-funded by Hevolution.

It’s all part of Hevolution’s plan to funnel up to $1 billion each year into academic research and biotech startups that are focused on aging-related diseases and and helping people live healthier lives longer, or what is sometimes referred to as “healthspan.” As part of that effort, the firm also announced at a conference in the Saudi capital of Riyadh this week that it will give around $80 million to a handful of research initiatives, including $21 million to establish a partnership with the Buck Institute for Research on Aging.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Do more moles mean more problems? Not so, says new study

WSS

iTeos Therapeutics debuts first data on TIGIT

At JPM 2024, hospital systems pitch financial strength to investors

What will save rural psychiatry services? Higher Medicaid payments

What will save rural psychiatry services? Higher Medicaid payments

Focused ultrasound for uterine fibroids: an uphill battle

At JPM 2024, hospital systems pitch financial strength to investors

explore

comprehensive

hotspot

Heart attack and stroke risk calculators need revising

Nonprofit, backed by Microsoft, to certify AI tools in health care

BioMarin wins approval for gene therapy to treat hemophilia A

Profiling embryos to choose those with higher IQs is almost a reality

Apple is now the first public company to be valued at $3 trillion

Male doctors called my cancer incurable. A female doctor showed it wasn't

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Ascension's ugly legal battle over care for poor patients in Texas

United colonoscopy coverage change 'may cost lives,' doctors say

Insmed lung disease drug hits target in key Phase 3 trial

entertainment

Childbirth

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Life science postdocs should get big pay hike, NIH panel says

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

explore

hotspot

focus

focus